scholarly journals Modern above-knee fitting practice (A report on the ISPO workshop on above-knee fitting and alignment techniques May 15–19, 1987, Miami, USA

1988 ◽  
Vol 12 (2) ◽  
pp. 77-90 ◽  
Author(s):  
C. M. Schuch

Introduction During the period of May 15–19, 1987, an International Workshop on Above-Knee Fitting and Alignment Techniques was held in Miami, Florida. Conceived and organized by A. Bennett Wilson, Jr. and Mel Stills, the workshop was supported and sponsored by the International Society for Prosthetics and Orthotics with the support of the Rehabilitation Research and Development Service of the Veteran's Administration. Hosting the workshop was the Prosthetics and Orthotics Education Programme of the School of Health Sciences, Florida International University, and more specifically, Dr. Reba Anderson, Dean of Health Sciences and Ron Spiers, Director of Prosthetic Orthotic Education. More than 50 physicians, prosthetists, engineers and educators from the United States, England, Scotland, Denmark, Sweden, Israel, the Netherlands and Germany participated.

2010 ◽  
Author(s):  
B. Mack Kennedy ◽  
Karsten Pruess ◽  
Marcelo J. Lippmann ◽  
Ernest L. Majer ◽  
Peter E. Rose ◽  
...  

1992 ◽  
Vol 19 (1) ◽  
pp. 51-78 ◽  
Author(s):  
Paul E. Nix ◽  
David E. Nix

This study reviews the literature and the practice of accounting for research and development (R&D) costs from the first reference in 1917 to the current treatment. The conceptual treatment of R&D is compared to current financial accounting rules and explanation of the evolution of the current rules is presented. The economic and social consequences of the current rules which require R&D costs to be expressed are examined. The paper explores possible alternative treatment of R&D costs. As a contrast to U.S. practice, the accounting treatment of R&D costs in other countries is discussed. Given the findings of this paper, a strong case can be made for changing the way that R&D costs are accounted for in the United States.


1993 ◽  
Vol 9 (2) ◽  
pp. 167-173 ◽  
Author(s):  
Michael R. Pollard

AbstractFueled by high returns on its investments, the pharmaceutical industry in the United States has flourished for the past 50 years. The regulatory strategy of demanding stringent testing then allowing market-based pricing has allowed private companies to fund ambitious research and development activities with the assurance that these investments will be recovered. However, aggressive managed-care cost-containment strategies threaten the companies' ability to recoup research and development expenses and may affect their willingness to invest in future innovative research.


Sign in / Sign up

Export Citation Format

Share Document